肿瘤微环境
癌症研究
免疫系统
免疫检查点
趋化因子
间质细胞
生物
免疫学
癌症
结直肠癌
免疫疗法
医学
骨髓
谷氨酰胺分解
重编程
细胞因子
癌症免疫疗法
肿瘤进展
促炎细胞因子
先天免疫系统
细胞毒性T细胞
炎症
CXCL1型
CXCL2型
T细胞
细胞
白细胞介素6
旁分泌信号
背景(考古学)
癌细胞
作者
Xiaoqing Liang,Dajin Yuan,Songyun Zhao,Jianbo Zhou,Kun Wang,Xiaoli Liu,Yin Liu,Huimin Li,Mengdi Hao,Wenbin Huang,Wenjie Li,Lei Ding
标识
DOI:10.1038/s41419-025-08064-3
摘要
Neutrophils are integral components of the bone marrow and stromal cell network. They express the immune checkpoint molecule PD-L1 and can induce T cell exhaustion, thereby promoting immunosuppression. In this study, we investigated whether tumor-derived Cldn7 deficiency could recruit polymorphonuclear neutrophils (PMNs), induce their metabolic reprogramming, and consequently drive their transition toward a pro-tumor phenotype, leading to the establishment of an immunosuppressive tumor microenvironment (TME). Using single-cell RNA sequencing, clinical sample validation, and both in vivo and in vitro experiments, we found that Cldn7 deficiency in colorectal cancer (CRC) results in a tumor microenvironment characterized by significantly increased infiltration of CD11b⁺ Ly6G⁺ neutrophils. This is accompanied by neutrophil metabolic reprogramming that facilitates their phenotypic shift toward a tumor-promoting state, which in turn suppresses the cytotoxic function of CD8⁺ T cells and contributes to the formation of an immunosuppressive TME, thereby accelerating CRC progression. Mechanistically, Cldn7 deficiency indirectly activates the NF-κB signaling pathway, leading to elevated secretion of chemokines such as CXCL1 that are responsible for PMN recruitment. Inhibition of the NF-κB/CXCL1 axis reduces PMN infiltration, decreases PD-L1 expression on neutrophils, suppresses neutrophil glycolysis and histone lactylation, reverses the exhausted phenotype of CD8⁺ T cells, thereby mitigating the immunosuppressive microenvironment. Furthermore, overexpression of Cldn7 enhances the efficacy of immune checkpoint blockade (ICB) therapy.Collectively, our findings indicate that Cldn7 deficiency not only contributes to immune evasion and malignant progression in CRC but also plays a critical role in immune modulation. Targeting PMN metabolic reprogramming and immunosuppressive function associated with Cldn7 loss may offer a promising strategy to improve the therapeutic efficacy of immunotherapy in CRC.
科研通智能强力驱动
Strongly Powered by AbleSci AI